Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin

Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin  Check out our extensive video library (see channel for our latest videos) Abstract Antiphospholipid syndrome (APS) represents a complex autoimmune disorder characterized by thrombotic events and pregnancy complications in patients with persistent antiphospholipid antibodies. The traditional anticoagulant

Anticoagulation Therapy In Risky Geriatric Cardiac Patients

Anticoagulation Therapy In Risky Geriatric Cardiac Patients In the realm of cardiovascular health, the coexistence of atrial fibrillation (AF) with heart failure (HF) presents a significant challenge for anticoagulation, particularly in the aging population. Uncertainties abound regarding treatment efficacy and patient outcomes. The All Nippon AF In the Elderly (ANAFIE) Registry,

Controversies in Antiphospholipid Syndrome: DOACs vs. Warfarin